Misa Imai
Impact in
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Virus-based gene therapy research
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 18
- Myeloproliferative Neoplasms: Diagnosis and Treatment 17
- Chronic Lymphocytic Leukemia Research 3
- Hematology 14
- Chronic Myeloid Leukemia Treatments 7
- Acute Myeloid Leukemia Research 6
- Platelet Disorders and Treatments 2
- Co-authors
- Marito Araki (16 shared papers)Norio Komatsu (17 shared papers)Hitoshi Kiyoi (2 shared papers)Akihiro Tomita (2 shared papers)Reona Sakemura (2 shared papers)Seitaro Terakura (2 shared papers)Tomoki Naoe (2 shared papers)Ryo Hanajiri (2 shared papers)
- Journals
- Experimental Hematology (2 papers)International Journal of Hematology (2 papers)Leukemia (2 papers)Cancer Science (2 papers)British Journal of Haematology (2 papers)
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Misa Imai
22 papers receiving 545 citations
Peers
Comparison fields: 5 of 58
- Genetics 160
- Hematology 129
- Oncology 248
- Immunology 91
- Molecular Biology 229
Countries citing papers authored by Misa Imai
This map shows the geographic impact of Misa Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misa Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misa Imai more than expected).
Fields of papers citing papers by Misa Imai
This network shows the impact of papers produced by Misa Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misa Imai. The network helps show where Misa Imai may publish in the future.
Co-authors
The 25 scholars most cited alongside Misa Imai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 227 | |
| 2 | 2012 | 66 | |
| 3 | 2018 | 45 | |
| 4 | 2019 | 40 | |
| 5 | 1998 | 38 | |
| 6 | 2017 | 27 | |
| 7 | 2017 | 20 | |
| 8 | 2018 | 18 | |
| 9 | 2019 | 10 | |
| 10 | 2020 | 10 | |
| 11 | 2020 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2019 | 7 | |
| 14 | 2015 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2015 | 4 | |
| 18 | 2021 | 3 | |
| 19 | [A case of primary myelofibrosis terminating in acute megakaryoblastic leukemia: identification by the demonstration of platelet peroxidase]. | 1984 | 3 |
| 20 | 2022 | 1 |
About Misa Imai
Misa Imai is a scholar working on Genetics, Hematology, Molecular Biology, Oncology and Rheumatology, having authored 25 papers that have together received 553 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Chronic Myeloid Leukemia Treatments (7 papers), Kruppel-like factors research (7 papers), Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Eosinophilic Disorders and Syndromes (3 papers), CAR-T cell therapy research (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Genetics (160 citations), Hematology (129 citations), Oncology (248 citations), Immunology (91 citations) and Molecular Biology (229 citations). Misa Imai has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Marito Araki, Norio Komatsu, Hitoshi Kiyoi, Akihiro Tomita, Reona Sakemura, Seitaro Terakura, Tomoki Naoe, Ryo Hanajiri, Keisuke Watanabe and Tetsuya Nishida. Their work appears in journals such as Experimental Hematology, International Journal of Hematology, Leukemia, Cancer Science and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.